Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHIELD: Isentress and Epzicom in ART-naive HIV Patients
NCT00740064Phase 4Unknown
- Sponsor
- Denver Infectious Disease Consultants
- Start
- May 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of raltegravir, abacavir + lamivudine in human immunodeficiency virus infection (HIV), sponsored by Denver Infectious Disease Consultants. Status: unknown.
02
Drugs
raltegravirabacavir + lamivudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00740064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00740064.